Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27833568 | 0.81 | — | — | |
| SCHEMBL27833554 | 0.81 | — | — | |
| SCHEMBL423889 | 0.81 | — | — | |
| SCHEMBL3763742 | 0.71 | PTGS1 (0.36) | PTGS1 | |
| SCHEMBL27654786 | 0.71 | PTGS1 (0.36) | PTGS1 | |
| SCHEMBL1444842 | 0.71 | PTGS1 (0.32) | PTGS1 | |
| SCHEMBL3263988 | 0.71 | PTGS1 (0.32) | PTGS1 | |
| SCHEMBL8517761 | 0.69 | — | — | |
| SCHEMBL11056456 | 0.67 | — | — | |
| SCHEMBL8938890 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2451765-B1 | PROCESS FOR THE MANUFACTURE OF HALOGENATED PRECURSORS OF ALKENONES UNDER SPECIFIC CONDITIONS | SOLVAY (BE) | 2016-12-28 | — | — | EP | disclosed |
| EP-2451763-B1 | PROCESS FOR THE MANUFACTURE OF HALOGENATED PRECURSORS OF ALKENONES IN THE PRESENCE OF A SOLVENT | SOLVAY (BE) | 2015-03-04 | — | — | EP | disclosed |
| US-8957254-B2 | Process for chemical synthesis from an alkenone made from a halogenated precursor | SOLVAY SA (BE) | 2015-02-17 | — | — | US | disclosed |
| US-20140051892-A1 | Process for chemical synthesis from an alkenone made from a halogenated precursor | SOLVAY SA (BE) | 2014-02-20 | — | — | US | disclosed |
| US-8552221-B2 | Process for the manufacture of halogenated precursors of alkenones under specific conditions | SOLVAY SA (BE) | 2013-10-08 | — | — | US | disclosed |
| US-8426650-B2 | Process for the manufacture of halogenated precursors of alkenones in the presence of a solvent | SOLVAY SA (BE) | 2013-04-23 | — | — | US | disclosed |
| EP-2451763-A1 | PROCESS FOR THE MANUFACTURE OF HALOGENATED PRECURSORS OF ALKENONES IN THE PRESENCE OF A SOLVENT | SOLVAY SA (BE) | 2012-05-16 | — | — | EP | disclosed |
| EP-2451765-A1 | PROCESS FOR THE MANUFACTURE OF HALOGENATED PRECURSORS OF ALKENONES UNDER SPECIFIC CONDITIONS | SOLVAY SA (BE) | 2012-05-16 | — | — | EP | disclosed |
| US-20120116128-A1 | Process For The Manufacture Of Halogenated Precursors Of Alkenones In The Presence Of A Solvent | SOLVAY SA (BE) | 2012-05-10 | — | — | US | disclosed |
| US-20120101305-A1 | Process For The Manufacture Of Halogenated Precursors Of Alkenones Under Specific Conditions | SOLVAY SA (BE) | 2012-04-26 | — | — | US | disclosed |
| WO-2011003856-A1 | PROCESS FOR THE MANUFACTURE OF HALOGENATED PRECURSORS OF ALKENONES UNDER SPECIFIC CONDITIONS | SOLVAY SA (BE) | 2011-01-13 | — | — | WO | disclosed |
| WO-2011003854-A1 | PROCESS FOR THE MANUFACTURE OF HALOGENATED PRECURSORS OF ALKENONES IN THE PRESENCE OF A SOLVENT | SOLVAY SA (BE) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101305-A1 | Process For The Manufacture Of Halogenated Precursors Of Alkenones Under Specific Conditions | HSD11B2, HSD17B12, HSD11B1 | PTGS1 3585/4885 |
| US-20120116128-A1 | Process For The Manufacture Of Halogenated Precursors Of Alkenones In The Presence Of A Solvent | ALK, HSD17B12, HSD17B10 | PTGS1 4222/4885 |
| US-20140051892-A1 | Process for chemical synthesis from an alkenone made from a halogenated precursor | ALK, CYP4A11, SQLE | PTGS1 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.